Super Trillion Common Light Chain Antibody Discovery Platform Launched
As One Of The Nine Trillion Antibody Discovery Platforms Of Sanyou, The Platform Features A Library Capacity Of Up To 1.12E+12 Cfu. For A Single Target, The Platform Can Generate Hundreds Of Lead Antibodies With Diverse Sequences, Which Can Be Further Designed Into Bispecific Antibodies With Good Drug Developability, Providing A Feasible Solution For Obtaining Bispecific Antibodies With Structures Similar To The Natural Monoclonal Antibodies.Bispecific Antibodies Are At The Forefront Of Antibody R&D Field. Compared With Monoclonal Antibodies, Bispecific Antibodies Possess One Additional Antigen Binding Arm, Which Brings Stronger Specificity And Better Targeting. As Of March Of 2023, 436 Bispecific Antibody Drug Candidates Have Advanced To Clinical Trials Worldwide, And 10 Bispecific Antibody Drugs Had Been Approved For Marketing, With Sales Of More Than 5 Billion Usd.The Antibody Library Of The Platform Was Established In A Rigorous Way. To Be Specific, 2 Common Light Chains Were Selected Through Alignment And Screening Of 1800+ Light Chain Sequences, Validation Of 25 Proof-Of-Concept Libraries, And Antibody Characterization And Analysis Of 12 Light Chains. The Bispecific Antibodies Generated By This Platform Exhibit Good Drug Developability, And The Heavy Chains Possess Natural Antibody Properties And High Diversity. The Platform Employs The Knob-Into-Hole Technology To Ensure The Correct Pairing In The Process Of Bispecific Antibody Formation And Eliminate The Mismatch. These Common Light Chain Antibodies Are Suitable For Multiple Application Scenarios, Such As Bispecific Antibody Development, Dual-Targeting Or Bi-Paratopic Adc, And Therapeutic Or Detection Antibodies.Following The Customer-Oriented Concept, The Platform Provides Two Types Of Services, I.E., Library Screening And Library Integration, Making It Not Only Suitable For The R&D Service Of Individual Projects, But Also For Customers
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!